MedTrace Logo

Caffeine in the Second Stage of Labor in Low-risk Nulliparous Mothers at Term

NCT05906303 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2023-09-14

No results posted yet for this study

Summary

Single blind, randomized control trial to determine benefit of caffeine and sodium benzoate on the second stage of labor

Conditions

  • Second Stage of Labor

Interventions

DRUG

Caffeine and Sodium Benzoate Injection

Provide caffeine to shorten second stage of labor and augment pushing efforts

DRUG

Normal Saline

Provide normal saline to serve as a placebo

Sponsors & Collaborators

  • The Reading Hospital and Medical Center

    lead OTHER

Principal Investigators

  • Daniel Jiang, MD · Reading Hospital Tower Health

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-01
Primary Completion
2024-12-01
Completion
2025-02-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05906303 on ClinicalTrials.gov